Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2004-05-17
2008-08-19
Davis, Brian J (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S503000, C564S507000, C564S512000, C514S665000, C514S671000, C514S674000
Reexamination Certificate
active
07414154
ABSTRACT:
The invention provides novel polyamine compounds and pharmaceutical compositions for administration in conjunction with cancer chemotherapy or radiation therapy. The compounds are administered locally to provide protection against the adverse side-effects of chemotherapy or radiation therapy, such as alopecia, mucositis and dermatitis. Pharmaceutical preparations comprising one or more chemoprotective polyamines formulated for topical or local delivery to epithelial or mucosal cells are disclosed. Methods of administering the pharmaceutical preparations are also disclosed.
REFERENCES:
patent: 3773833 (1973-11-01), Henrici et al.
patent: 5217964 (1993-06-01), Edwards et al.
patent: 5292497 (1994-03-01), Schein et al.
patent: 5434145 (1995-07-01), Edwards et al.
patent: 5541230 (1996-07-01), Basu et al.
patent: 5627215 (1997-05-01), Frei et al.
patent: 5889061 (1999-03-01), Frydman et al.
patent: 5962533 (1999-10-01), Bergeron, Jr.
patent: 6172261 (2001-01-01), Vermeulin et al.
patent: 6239119 (2001-05-01), Stogniew et al.
patent: 2003/0022867 (2003-01-01), Stogniew et al.
patent: 2003/0118539 (2003-06-01), Fahl et al.
patent: WO 94/19311 (1994-09-01), None
patent: WO 94/27961 (1994-12-01), None
patent: WO 98/17624 (1998-04-01), None
patent: WO 00/66587 (2000-11-01), None
patent: WO 00/78289 (2000-12-01), None
patent: WO 01/85142 (2001-11-01), None
patent: WO 02/38105 (2002-05-01), None
patent: WO 03/013245 (2003-02-01), None
Database CAPLUS on STN, Acc No. 1999:77533, Vermeulin et al., WO 9903823 (Dec. 8, 1999) (CAPLUS abstract).
Database CAPLUS on STN, Acc. No. 1971:437363, Yamauchi et al., JP 45034456 (Nov. 5, 1970) (abstract).
Supportive Care in Cancer, 2004, 12(8), p. 543-549.
Supportive Care in Cancer, 1997, 5(2), p. 139-143 (abstract).
Cancer Treatment Reviews, 2006, 32(8), p. 645-651.
The PCT International Search Report dated Jul. 11, 2003 (PCT/US03/03607).
Aprahamian, M., et al., “Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine,”Biol. of the Cell, 1987, 61, 69-76.
Basu, H.S., et al., “The interaction of spermine and pentamines with DNA,”Biochem. J., 1987, 244, 243-246.
Basu, H.S., et al., “Effects of variation in the structure of spermine on the association with DNA and the aduction of DNA conformational changes,”Biochem. J., 1990, 269, 329-334.
Chen, G., et al., “Protection against cyclophosphamide-induced alopecia and inhibition of mammary tumor growth by topical 1,25-dihydroxyvitamin d3in mice,”Int. J. Cancer, 1998, 75, 303-309.
Creaven, P.J., et al., “Unusual central nervous system toxicity in a phase I study of N1N11diethylnorspermine in patients with advanced malignancy,”Invest. New Drugs, 1997, 15, 227-234.
Ellouk-Achard, S., et al., “Ex Vivo and in Vitro models in acetaminophen hepatotoxicity studies. Relationship between glutathione depletion, oxidative stress and disturbances in calcium homeostasis and energy metabolism,”Arch. Toxicol. Suppl., 1995, 17, 209-214.
Feuerstein, B.G., et al., “Molecular dynamics of spermine-DNA interactions: sequence specificity and DNA bending for a simple ligand,”Nuc. Acids Res., 1989, 17(17), 6883-6892.
Ho, D., et al., “Modification of glutathione levels in C3H/1OT1/2 cells and its relationship to benzo(α)pyrene anti-7,8-dihydrodiol 9,10-epoxide-induced cytotoxicity,”J. Biol. Chem., Sep. 24, 1984, 259(18), 11231-11235.
Huber, M., “2,2′ -Dithiobis(N-ethyl-spermine-5-carboxamide) is a high affinity, membrane-impermeant antagonist of the mammalian polyamine,”J. of Biol. Chem., 1996, 271(44), 27556-27563.
Hussein, A.M., et al., “Protection from chemotherapy-induced alopecia in a rat model,”Science, Sep. 28, 1990, 249, 1564-1566.
Kramer, D.L., et al., “Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1arrest in human melanoma cells,”Cancer Res., Mar. 15, 1999, 59, 1278-1286.
Kramer, D.L., et al., “Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells,”Cancer Res., Dec. 15, 1997, 57, 5521-5527.
Levy, E.J., et al., “Transport of glutathione diethyl ester into human cells,”Proc. Natl. Acad. Sci. USA, Oct. 1, 1993, 90(19), 9171-9175.
March, J., Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 4thEd.,John Wiley&Sons, New York, 1992, 771-780.
Masuda, K., et al., “Response of previously irradiated mouse skin to a second course of irradiation: early skin reaction and skin shrinkage,”Int. J. Radiation Oncol. Biol. Phys., 1986, 12, 1645-1651.
Sonis, S.T., et al., “Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters,”Oral Oncology, 2000, 36, 373-381.
Spotheim-Maurizot, M., “Radioprotection of DNA by polyamines,”Int. J. Radiat. Biol., 1995, 68(5), 571-577.
Streiff, R., et al., “Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignancies,”Invest. New Drugs, 2001, 19, 29-39.
U.S. Appl. No. 09/565,714, filed May 5, 2000, Fahl et al.
U.S. Appl. No. 10/214,917, filed Aug. 7, 2002, Fahl et al.
Alvarez, E., et al., “Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis,”Clin. Cancer Research, 2003, 9, 3454-3461.
Basu, H., et al., “Correlation between the effects of polyamine analogues on DNA conformation and cell growth,”Cancer Res., 1989, 49, 5591-5597.
Desai, M.P., et al., “The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent,”Pharm. Res., 1997, 14(11), 1568-1573.
Gao, X., et al., “Radioprotective effect of epinephrine as a vasoconstrictor in mouse oral mucosa and scalp,”Okayama Igakkai Zasshi, 1996, 108, 139-144 (Translation).
Hillery, A.M., et al., “Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60nm polystyrene particles,”J. Drug Targeting, 1994, 2, 151-156.
Jayaraman, S.C., et al., “Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study,”J. Pharm. Sci., 1996, 85, 1082-1084.
Jeitner, T.M., et al., “Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine,”Cancer Lett., 1996, 103, 85-90.
Kramer, D.L., et al., “Polyamine depletion in human melanoma cells leads to G1arrest associated with induction of p21WAF1/CIP1/SD11, changes in the expression of p21-regulated genes, and a senescence-like phenotype,”Cancer Res., 2001, 61, 7754-7762.
Lowy, R.O., et al., “Protection against local irradiation injury to the skin by locally and systemically applied drugs,”Radiation Biology, 1972, 105, 425-428.
Purdie, J.W., “A comparative study of the radioprotection effects of cysteamine, WR-2721, and WR-1065 in cultured human cells,”Radiation Res., 1979, 77, 303-311.
Snyder, R.D., et al., “Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II,”Cancer Res., 2000, 60, 1186-1188.
Verhey, L.J., et al., “Determination of the radioprotective effects of topical applications of MEA, WR-2721,N-acetylcysteine on murine skin,”Radiation Res., 1983, 93, 175-183.
Copp, Jr. Richard R.
Fahl Kathleen L.
Fahl William E.
Ochsner Cynthia E.
Peebles Daniel D.
Davis Brian J
Quarles & Brady LLP
Wisconsin Alumni Research Foundation
LandOfFree
Polyamine compounds and compositions for use in conjunction... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyamine compounds and compositions for use in conjunction..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyamine compounds and compositions for use in conjunction... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4020018